Frederic Caux
Overview
Explore the profile of Frederic Caux including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
79
Citations
1492
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tedbirt B, Houivet E, Maho-Vaillant M, Golinski M, Calbo S, Prost-Squarcioni C, et al.
JAMA Dermatol
. 2025 Mar;
PMID: 40042819
No abstract available.
2.
Bal E, Park H, Belaid-Choucair Z, Kayserili H, Naville M, Madrange M, et al.
Nat Med
. 2025 Feb;
PMID: 39915680
No abstract available.
3.
Hebert V, Hamwi S, Tancrede-Bohin E, Quereux G, Pham-Ledard A, Caux F, et al.
JAMA Dermatol
. 2025 Feb;
PMID: 39908046
Importance: Rituximab is approved for the treatment of moderate to severe pemphigus. However, 20% of patients in the RITUX 3 trial relapsed within the first year of treatment. Objective: To...
4.
Karakioulaki M, Dunn P, Murrell D, Payne A, Schmidt E, Werth V, et al.
JID Innov
. 2025 Jan;
5(2):100339.
PMID: 39877685
No abstract available.
5.
Margot H, Jones N, Matis T, Bonneau D, Busa T, Bonnet F, et al.
J Med Genet
. 2024 Oct;
61(12):1071-1079.
PMID: 39358013
Background: PTEN hamartoma tumour syndrome (PHTS) encompasses distinct syndromes, including Cowden syndrome resulting from pathogenic variants. Missense variants account for 30% of PHTS cases, but their classification remains challenging. To...
6.
Tzoumpa S, Bejar C, Villette B, Louveau B, Zelek L, Martin A, et al.
J Eur Acad Dermatol Venereol
. 2024 Aug;
39(3):e283-e286.
PMID: 39115046
No abstract available.
7.
Delvaux C, Bohelay G, Sitbon I, Soued I, Alexandre M, Cucherousset J, et al.
Front Immunol
. 2024 Jul;
15:1404185.
PMID: 38983857
Introduction: Although the treatment for pemphigus vulgaris (PV) has been revolutionized by the use of rituximab combined with corticosteroids, new effective therapies with a better safety profile are needed. Observation:...
8.
Bohelay G, Guyot A, Billard-Pomares T, Marsollier L, Caux F, Carbonnelle E
Travel Med Infect Dis
. 2024 May;
60:102725.
PMID: 38754530
no abstract requested for correspondance items.
9.
Combemale L, Bohelay G, Sitbon I, Ahouach B, Alexandre M, Martin A, et al.
Front Immunol
. 2024 Apr;
15:1243566.
PMID: 38686381
Background: Lichen planus pemphigoides (LPP), an association between lichen planus and bullous pemphigoid lesions, is a rare subepithelial autoimmune bullous disease. Mucous membrane involvement has been reported previously; however, it...
10.
Murrell D, Caux F, Patsatsi A, Hagino O, Rudnicka L, Vassileva S, et al.
J Invest Dermatol
. 2024 Mar;
144(8):1762-1771.e6.
PMID: 38493933
Trial Design: Pemphigus is a rare but life-threatening autoimmune disease requiring long-term treatment that minimizes corticosteroid (CS) exposure while providing consistent disease control. The phase 2 pemphigus study of oral,...